These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26900856)

  • 41. Purification and characterization of a soluble calnexin from human placenta.
    Olsen DT; Peng L; Træholt SD; Duus K; Højrup P; Houen G
    Protein Expr Purif; 2013 Nov; 92(1):105-11. PubMed ID: 24056258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cleavage of calnexin caused by apoptotic stimuli: implication for the regulation of apoptosis.
    Takizawa T; Tatematsu C; Watanabe K; Kato K; Nakanishi Y
    J Biochem; 2004 Sep; 136(3):399-405. PubMed ID: 15598898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycan specificity of a testis-specific lectin chaperone calmegin and effects of hydrophobic interactions.
    Sakono M; Seko A; Takeda Y; Aikawa J; Hachisu M; Koizumi A; Fujikawa K; Ito Y
    Biochim Biophys Acta; 2014 Sep; 1840(9):2904-13. PubMed ID: 24769397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potent lectin-independent chaperone function of calnexin under conditions prevalent within the lumen of the endoplasmic reticulum.
    Brockmeier A; Williams DB
    Biochemistry; 2006 Oct; 45(42):12906-16. PubMed ID: 17042509
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ionomycin on interaction of calnexin with vesicular stomatitis virus glycoprotein is cell type-specific.
    Okudera M; Gojoubori T; Tsujino I; Asano M
    J Oral Sci; 2015; 57(4):305-12. PubMed ID: 26666853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein S-palmitoylation in cellular differentiation.
    Zhang MM; Hang HC
    Biochem Soc Trans; 2017 Feb; 45(1):275-285. PubMed ID: 28202682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin.
    Oda Y; Hosokawa N; Wada I; Nagata K
    Science; 2003 Feb; 299(5611):1394-7. PubMed ID: 12610305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs.
    Cabral CM; Liu Y; Moremen KW; Sifers RN
    Mol Biol Cell; 2002 Aug; 13(8):2639-50. PubMed ID: 12181335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent glycoprotein misfolding activates the glucosidase II/UGT1-driven calnexin cycle to delay aggregation and loss of folding competence.
    Molinari M; Galli C; Vanoni O; Arnold SM; Kaufman RJ
    Mol Cell; 2005 Nov; 20(4):503-12. PubMed ID: 16307915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutational analysis of calnexin.
    Groenendyk J; Dabrowska M; Michalak M
    Biochim Biophys Acta; 2011 Jun; 1808(6):1435-40. PubMed ID: 20385098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase of calnexin gene dosage boosts the secretion of heterologous proteins by Hansenula polymorpha.
    Klabunde J; Kleebank S; Piontek M; Hollenberg CP; Hellwig S; Degelmann A
    FEMS Yeast Res; 2007 Oct; 7(7):1168-80. PubMed ID: 17617219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assembly and retention of CD1b heavy chains in the endoplasmic reticulum.
    Sugita M; Porcelli SA; Brenner MB
    J Immunol; 1997 Sep; 159(5):2358-65. PubMed ID: 9278326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved prediction of palmitoylation sites using PWMs and SVM.
    Li YX; Shao YH; Deng NY
    Protein Pept Lett; 2011 Feb; 18(2):186-93. PubMed ID: 21054270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro assays of the functions of calnexin and calreticulin, lectin chaperones of the endoplasmic reticulum.
    Ireland BS; Niggemann M; Williams DB
    Methods Mol Biol; 2006; 347():331-42. PubMed ID: 17072021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-related decline in expression of calnexin.
    Choi BH; Kim JS
    Exp Mol Med; 2004 Oct; 36(5):499-503. PubMed ID: 15557823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell viability and secretion of active proteins in Schizosaccharomyces pombe do not require the chaperone function of calnexin.
    Maréchal A; Tanguay PL; Callejo M; Guérin R; Boileau G; Rokeach LA
    Biochem J; 2004 Jun; 380(Pt 2):441-8. PubMed ID: 14984369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visualizing Wnt Palmitoylation in Single Cells.
    Gao X; Hannoush RN
    Methods Mol Biol; 2016; 1481():1-9. PubMed ID: 27590146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membrane.
    Itakura M; Tsujimura J; Yamamori S; Ohkido T; Takahashi M
    Neurosci Lett; 2013 Aug; 550():173-8. PubMed ID: 23851254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-translational palmitoylation controls the voltage gating and lipid raft association of the CALHM1 channel.
    Taruno A; Sun H; Nakajo K; Murakami T; Ohsaki Y; Kido MA; Ono F; Marunaka Y
    J Physiol; 2017 Sep; 595(18):6121-6145. PubMed ID: 28734079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dynamics of CLIMP-63 S-acylation control ER morphology.
    Sandoz PA; Denhardt-Eriksson RA; Abrami L; Abriata LA; Spreemann G; Maclachlan C; Ho S; Kunz B; Hess K; Knott G; S Mesquita F; Hatzimanikatis V; van der Goot FG
    Nat Commun; 2023 Jan; 14(1):264. PubMed ID: 36650170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.